A Harvard Medical School team has linked lithium and Alzheimer’s in a way that could change brain treatment.
In brain tissue from people with mild cognitive impairment and Alzheimer’s, researchers found lithium levels were markedly lower.
While in mice, restoring lithium reversed Alzheimer’s like memory loss and brain changes.
Human trials are now the next step.
Lithium and Alzheimer’s: mice regained memory; human trials next
Published in Nature, the study shows lithium occurs naturally in the brain.
In addition, it is tied up by amyloid plaques as disease begins, reducing its availability for normal cell function.
A lithium compound that evades amyloid “capture” (lithium orotate) restored memory and prevented damage in older, memory-impaired mice; even at very low doses.
Lead author Bruce Yankner says the data point to lithium deficiency as an early driver of disease and a fresh path for therapy.
The work also helps explain earlier observations that regions with slightly higher lithium in drinking water report lower dementia rates.
For families and clinicians, the potential is clear. If human studies confirm these results, lithium could become an affordable, scalable part of Alzheimer’s prevention and treatment.
Why this matters for Pakistan
An effective, low cost therapy would expand access beyond elite clinics.
With Pakistan’s aging population and rising dementia burden, validated lithium protocols—if proven in humans—could be integrated into public hospitals and memory clinics with proper monitoring and training.
